1
|
Kavitha N, Thamilarasan V, Sengottuvelan N. Diketonato based ferrocene appended cyclometalated iridium(III) complexes: Anti-microbial and anti-cancer studies. J Organomet Chem 2021. [DOI: 10.1016/j.jorganchem.2021.122032] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
2
|
Akrami H, Mirjalili BF, Firuzi O, Hekmat A, Saboury AA, Miri R, Sabzevari O, Pirali-Hamedani M, Jeivad F, Moghimi S, Emami S, Foroumadi A, Khoobi M. Cytotoxic Activity and DNA Binding Property of New Aminopyrimidine Derivatives. LETT DRUG DES DISCOV 2020. [DOI: 10.2174/1570180816666190712102119] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
Abstract
Background:
Chromene and anilinopyrimidine heterocyclics are attractive anticancer
compounds that have inspired many researchers to design novel derivatives bearing improved anticancer
activity.
Methods:
A series of pyrimidine-fused benzo[f]chromene derivatives 6a-x were synthesized as
anticancer hybrids of 1H-benzo[f]chromenes and anilinopyrimidines. The inhibitory activity of the
synthesized compounds 6a-x against cell viability of human chronic myelogenous leukemia
(K562), human acute lymphoblastic leukemia (MOLT-4) and human breast adenocarcinoma
(MCF-7) cell lines was evaluated using MTT assay. The interaction of the most promising compound
with calf-thymus DNA was also studied using spectrometric titrations and Circular Dichroism
(CD) spectroscopy.
Results:
Most compounds showed promising activity against tested cell lines. Among them, 2,4-
dimethoxyanilino derivative 6g exhibited the best profile of activity against tested cell lines
(IC50s = 1.6-6.1 μM) with no toxicity against NIH3T3 normal cell (IC50 >200 μM). The spectrometric
studies exhibited that compound 6g binds to DNA strongly and may change DNA conformation
significantly, presumably via a groove binding mechanism.
Conclusion:
The results of this study suggest that the prototype compound 6g can be considered as
a novel lead compound for the design and discovery of novel anticancer agents.
Collapse
Affiliation(s)
- Hamidreza Akrami
- The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| | - Bibi Fatemeh Mirjalili
- Department of Chemistry, College of Science, Yazd University, Yazd, PO Box 8915813149, Iran
| | - Omidreza Firuzi
- Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Azadeh Hekmat
- Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
| | - Ali Akbar Saboury
- Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
| | - Ramin Miri
- Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Omid Sabzevari
- Toxicology and Poisoning Research Centre, Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Morteza Pirali-Hamedani
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Fereshteh Jeivad
- Toxicology and Poisoning Research Centre, Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Setareh Moghimi
- The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| | - Saeed Emami
- Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
| | - Alireza Foroumadi
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Mehdi Khoobi
- The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
3
|
Erkan S, Karakaş D. A theoretical study on cyclometalated iridium (III) complexes by using a density functional theory. JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY 2020. [DOI: 10.1142/s0219633620500066] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Cyclometalated iridium (III) complexes (Ir1–Ir4) are calculated in detail with computational chemistry methods. The calculated structural parameters of Ir3 are compared with experimental values and a good fit is obtained. IR spectra are calculated at B3LYP/LANL2DZ/6-31G(d) level in the gases phase. Calculated 1H-NMR chemical shift values of the mentioned complexes are compared with the experimental data and all chemical shifts are assigned to the respective atoms. The quantum chemical parameters such as absolute hardness ([Formula: see text]), absolute softness ([Formula: see text]) electronegativity ([Formula: see text]), chemical potential ([Formula: see text]) and electronic charges ([Formula: see text]) are calculated and are associated with the experimental anti-cancer properties of the related complexes. Nonlinear optic properties of the Ir1–Ir4 were investigated with the average linear polarizability ([Formula: see text]), the anisotropy of the polarizability ([Formula: see text]), first hyperpolarizability ([Formula: see text]) values. Hole transfer ([Formula: see text]), electron transfer integrals ([Formula: see text]), hole reorganization energies ([Formula: see text]) and electron reorganization energies ([Formula: see text]) are examined. In addition, molecular docking study was performed. It was found that the molecular docking results are similar to the experimental anti-cancer trend.
Collapse
Affiliation(s)
- Sultan Erkan
- Yıldızeli Vocational School, Chemical and Chemical Company Technology, Cumhuriyet University, Sivas, Turkey
| | - Duran Karakaş
- Science Faculty, Department of Chemistry, Cumhuriyet University, 58140 Sivas, Turkey
| |
Collapse
|